Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
  1. 4 Open-market sale Chief Medical Officer sold 29,000 shares at an average $37.18 ($1,078,261)
  2. 4 Open-market sale Chief Medical Officer sold 60,000 shares at an average $34.82 ($2,089,472)
  3. 4 Open-market sale General Counsel and Secretary sold 16,926 shares at an average $29.15 ($493,398)
  4. 4 Open-market sale General Counsel and Secretary sold 1,597 shares at an average $28.37 ($45,311)
  5. 4 Open-market sale General Counsel and Secretary sold 16,256 shares at an average $28.12 ($457,077)
  6. 4 Open-market sale General Counsel and Secretary sold 8,125 shares at $22.05 ($179,156)
  7. 4 Open-market buy Director bought 425,531 shares at $23.50 ($9,999,979)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Chief Executive Officer sold 30,000 shares at $12.20 ($366,000)
  14. 4 Open-market sale Chief Executive Officer sold 30,000 shares at $13.04 ($391,200)
  15. 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $18.92 ($567,636)
  16. 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $17.65 ($529,491)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $19.09 ($572,818)

Page 5 of 14 · 264 filings